Cholesterol-induced ROS overexpression accelerates the onset of AD neuropathological hallmarks including amyloid-β deposition and tau phosphorylation in the APP/PS1/SREBP2 transgenic mouse model [47]. Here, MAPT is linked to Alzheimer disease.